CP-0597

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCP-0597

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBradykinin B2 receptor antagonists

TargetsBradykinin B2 receptor

Therapy Area/IndicationsStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCortech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCortech

Active IndicationsN/A

Inactive IndicationsStroke

ATC CodeN/A